Focus: Francis Medical is a public biotechnology company headquartered in Minnesota specializing in water vapor prostate ablation and related oncology/cardiovascular technologies. The company operates across multiple therapeutic modalities including diagnostics, small molecules, and procedural devices.
Profile data last refreshed 16h ago · AI intelligence enriched 2w ago
Recent layoff filing — 66 affected
Source: state DOL filings via Big Local News
No open roles listed right now. Follow Francis Medical to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Approved NDA product at peak commercial stage; represents Francis Medical's primary marketed diagnostic asset.
Help build intelligence for Francis Medical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Francis Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Francis Medical Announces Further Expansion of Commercial Vanquish® Procedures to Ablate Prostate Tissue - PR Newswire
Francis Medical Announces Further Expansion of Commercial Vanquish® Procedures to Ablate Prostate Tissue PR Newswire
Francis Medical Announces First Commercial Vanquish® Procedure to Ablate Prostate Tissue in the Midwest - PR Newswire
Francis Medical Announces First Commercial Vanquish® Procedure to Ablate Prostate Tissue in the Midwest PR Newswire
Francis Medical Announces Further Commercial Expansion of Vanquish® Water Vapor Ablation with First Commercial Procedures to Ablate Targeted Prostate Tissue in the Southeast - PR Newswire
Francis Medical Announces Further Commercial Expansion of Vanquish® Water Vapor Ablation with First Commercial Procedures to Ablate Targeted Prostate Tissue in the Southeast PR Newswire
Novartis settles with estate of Henrietta Lacks over use of 'stolen' cells - VPM
Novartis settles with estate of Henrietta Lacks over use of 'stolen' cells VPM
Ukraine’s Population Crisis and Health at the State of the Union - Think Global Health
Ukraine’s Population Crisis and Health at the State of the Union Think Global Health
No open positions listed yet. Check their careers page directly.
Source: USCIS H-1B Employer Data Hub
Source: state DOL filings, aggregated via Big Local News
Significant restructuring risk: a 66-person facility closure is substantial for a biotech and signals cost rationalization, potential further consolidations, and uncertain job security across the organization.
Recent peer-reviewed publications with author affiliations at this company
Showing 5 of 10 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo